Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus

Journal of General Virology

Volumn 77, Issue 12, 1996, Pages 2969-2981

  Stahl Hennig, Christiane ^a   Dittmer, Ulf ^a   Nißlein, Thomas ^a   Petry, Harald ^a   Jurkiewicz, Elke ^a   Fuchs, Dietmar ^b   Wachter, Helmut ^b   Mätz Rensing, Kerstin ^a   Kuhn, Eva Maria ^a   Kaup, Franz Josef ^a   Rud, Erling W ^c   Hunsmann, Gerhard ^a  

^a GERMAN PRIMATE CENTER   (Germany)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c LAB CENTRE FOR DISEASE CONTROL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; NEF PROTEIN; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DELETION MUTANT; GENE DELETION; HELPER CELL; HUMORAL IMMUNITY; INTRAVENOUS DRUG ADMINISTRATION; MACACA; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINATION; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS MUTANT;

ANIMALIA; MACACA; MACACA MULATTA; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 8044235815     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-77-12-2969     Document Type: Article

References (41)

1. Ahmad, S., Lohmann, B., Marthas, M., Giavedoni, L., EI-Ahmad, Z., Haigwood, N., Scandella, C., Gardner, M., Luciw, P. & Yilma, T. (1994). Reduced virus load in rhesus macaques immunised with recombinant gp 160 and challenged with simian immunodeficiency virus. AIDS Research and Human Retroviruses 10, 195-204.
2. Almond, N., Kent, K., Cranage, M., Rud, E., Clarke, B. & Stott, E. J. (1995). Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. Lancet 345, 1342-1344.
3. Baba, T. W., Jeong, Y. S., Penninek, D., Bronson, R., Greene, M. F. & Ruprecht, P. M. (1995). Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science 267, 1820-1825.
4. Bachmann, B., Lüke, W. & Hunsmann, G. (1992). Improvement of PCR amplified DNA sequencing with the aid of detergents. Nucleic Acids Research 18, 1309.
5. Benveniste, O., Vaslin, B., Le Grand, R., Cheret, A., Matheux, F., Theodoro, F., Cranage, M. P. & Dormont, D. (1996). Comparative interleukin (IL)-2/interferon (IFN)-γ and IL-4/IL-10 responses during acute infection of macaques inoculated with attenuated nef-truncated or pathogenic SIVmac251 virus. Proceedings of the National Academy of Sciences, USA 93, 3658-3663.
6. Cranage, M. P., Cook, N., Johnstone, P., Greenaway, P. J., Kitchin, P. A., Stott, E. J., Almond, N. & Baskerville, A. (1990). SIV infection of rhesus macaques: in vitro titration of infectivity and development of an experimental vaccine. In Animal Models in AIDS, pp. 103-114. Edited by H. Schellekens & M. C. Horzinek. Amsterdam, Holland: Elsevier, Biomedical Press.
7. Daniel, M. D., Kirchoff, F., Czajak, S. C., Sehgal, P. K. & Desrosiers, R. C. (1992). Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258, 1938-1941.
8. Desrosiers, R. C., Wyand, M. S., Kodama, T., Ringler, D. J., Arthur, L. O., Segal, P. K., Letvin, N. L., King, N. W. & Daniel, M. D. (1989). Vaccine protection against simian immunodeficiency virus infection. Proceedings of the National Academy of Sciences, USA 86, 6353-6357.
9. Dittmer, U., Luke, W., Stahl-Hennig, C., Coulibaly, C., Petty, H., Bodemer, H., Hunsmann, G. & Voss, G. (1994). Early helper T-cell dysfunction in simian immunodeficiency virus but not in human immunodeficiency virus type-2-infected macaques. Journal of Medical Primatology 23, 298-303.
10. Dittmer, U., Stahl-Hennig, C., Coulibaly, C., Nisslein, T., Lüke, W., Fuchs, D., Bodemer, W., Petry, H. & Hunsmann, G (1995a). Repeated exposure of rhesus macaques to low doses of simian immunodeficiency virus (SIV) did not protect them against the consequences of a high-dose SIV challenge. Journal of General Virology 76, 1307-1315.
11. Dittmer, U., Nisslein, T., Bodemer, W., Retry, H., Sauermann, U., Stahl-Hennig, C. & Hunsmann, G. (1995b). Cellular immune response of rhesus monkeys infected with a partially attenuated nef mutant of the simian immunodeficiency virus. Virology 212, 392-397.
12. Fendrich, C., Luke, W., Stahl-Hennig, C., Herchenröder, O., Fuchs, D., Wachter, H. & Hunsmann, G. (1989). Urinary neopterin concentrations in rhesus monkeys after infection with simian immunodeficiency virus strain 251. AIDS 3, 305-307.
13. Franchini, G., Robert-Guroff, M., Tartaglia, J., Aggarwal, A., Abimiku, A., Benson, J., Markham, P., Limbach, K., Hurteau, G., Fullen, J., Aldrich, K., Miller, N., Sadoff, J., Paoletti, E. & Gallo, R. C. (1995). Highly attenuated HIV type 2 recombinant poxviruses, but not HIV-2 recombinant Salmonella vaccines, induce long-lasting protection in rhesus macaques. AIDS Research and Human Retroviruses 11, 909-920.
14. Fuchs, D., Hausen, R., Reibnegger, G., Werner, E. R., Dierich, M. P. & Wachter, H. (1988). Neopterin as a marker for activated cell-mediated immunity: application in HIV infection. Immunology Today 9, 150-155.
15. Gallimore, A., Cranage, M., Cook, N., Almond, N., Bootman, J., Rud, E., Silvera, P., Dennis, M., Corcoran, T., Stott, J., McMichael, A. & Gotch, F. (1995). Early suppression of SIV replication by CD8 + nef-specific cytotoxic T cells in vaccinated macaques. Nature Medicine 1, 1167-1173.
16. Giavedoni, L., Planelles, V., Haighwood, N., Ahmad, S., Klug, J., Marthas, M., Gardner, M., Luciw, P. & Yilma, T. (1993). Immune response of rhesus macaques to recombinant SIV gp130 does not protect from challenge infection. Journal of Virology 67, 577-583.
17. Harada, S., Purtilo, D., Koyanagi, Y., Sonnabend, J. & Yamamoto, N. (1986). Sensitive assay for neutralising antibodies against AIDS-related viruses (HTLV-III/LAV). Journal of Immunological Methods 92, 177-181.
18. Hasenkrug, K. J., Brooks, D. M., Nishio, J. & Chesebro, B. (1996). Differing T-cell requirements for recombinant retrovirus vaccines. Journal of Virology 70, 386-372.
19. Hoch, J., Lang, S. M., Weeger, M., Stahl-Hennig, C., Coulibaly, C., Dittmer, U., Hunsmann, G., Fuchs, D., Müller, J., Sopper, S., Fleckenstein, B. & Überla, K. (1995). vpr deletion mutant of simian immunodeficiency virus induces AIDS in rhesus monkeys. Journal of Virology 69, 4807-4813.
20. Hu, S.-L., Abrams, K., Barber, G. N., Moran, P., Zarling, J. M., Langlois, A. J., Kuller, L., Mortan, W. R. & Benveniste, R. E. (1992). Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160. Science 255, 456-459.
21. Israel, Z. R., Edmonson, P. F., Maul, D. H., O'Neil, S. P., Mossman, S. P., Thiriart, C., Farby, L., Van Opstal, O., Bruck, C., Bex, F., Burny, A., Fultz, P. N., Mullins, J. I. & Hoover, E. A. (1994). Incomplete protection, but suppression of virus burden, elicited by subunit simian immunodeficiency virus vaccines. Journal of Virology 68, 1843-1853.
22. Joag, S. V., Stephens, E. B., Adams, R. J., Foresman, L. & Narayan, O. (1994). Pathogenesis of SIVmac infection in Chinese and Indian rhesus macaques: effects of splenectomy on virus burden. Virology 200, 436-466.
23. Jurkiewicz, E., Jansen, R., Kunze, B., Trowitzsch-Kienast, W., Forche, E., Reichenbach, H., Höfle, G. & Hunsmann, G. (1992). Three new potent HIV-1 inhibitors from myxobacteria. Antiviral Chemistry and Chemotherapy 3, 189-193.
24. Kestler, H. W., Ringler, D. J., Mori, K., Panicali, D. L., Sehgal, P., Daniel, M. D. & Desrosiers, R. C. (1991). Importance of the nef gene for maintenance of high virus loads and for development of AIDS, Cell 65, 651-662.
25. Lang, S. M., Weeger, M., Stahl-Hennig, C., Coulibaly, C., Hunsmann, G., Müller, J., Müller-Hermelink, H., Fuchs, D., Wachter, H., Daniel, M. D., Desrosiers, R. C. & Fleckenstein, B. (1993). Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus. Journal of Virology 67, 902-912.
26. Lüke, W., Voss, G., Stahl-Hennig, C., Coulibaly, C., Petry, H. & Hunsmann, G. (1993). Protection of cynomolgus macaques against infection by the human immunodeficiency virus type 2 strain ben (HIV-2ben) through immunization with the virion-derived envelope glycoprotein gp130. AIDS Research and Human Retroviruses 9, 387-394.
27. Luke, W., Coulibaly, C., Dittmer, U., Voss, G., Oesterle, R., Makoschey, B., Sauermann, U., Jurkiewicz, E., Stahl-Hennig, C., Petry, H. & Hunsmann, G. (1996). Simian immunodeficiency virus (SIV) gp130 oligomers protect rhesus macaques (Macaca mulatta) against infection with SIVmac32H grown on T-cells or derived ex vivo. Virology 216, 444-450.
28. Mills, K., Page, M., Chan, L., Kitchin, P., Stott, J., Taffs, F., Jones, W., Rose, J., Ling, C., Silvers, P., Corcoran, T., Flanagan, B., Burny, A., Bex, F., Delchambre, M., Vanopstal, O., Fabry, L., Thirart, C., Delers, A., Dewilde, M. & Bruck, C. (1992). Protection against SIV infection in macaques by immunization with inactivated virus from the BK28 molecular clone, but not with BK28-derived recombinant env and gag proteins. Journal of Medical Primatology 21, 50-57.
29. Miyazawa, M., Fujisawa, R., Ishihara, C., Takei, Y. A., Shimizu, T., Uenishi, H., Yamagishi, H. & Kuribayashi, K. (1995). Immunization with a single T helper cell epitope abrogates Friend virus-induced early erythroid proliferation and prevents late leukemia development. Journal of Immunology 155, 748-758.
30. Murphy-Corb, M., Martin, L. N., Davison-Fairburn, B., Montelaro, R., Miller, M., West, M., Ohkawa, S., Baskin, G. B., Zhang, J. Y., Putney, S., Allison, A. S. & Eppstein, D. (1989). A formalin-inactivated whole SIV vaccine confers protection in macaques. Science 246, 1293-1297.
31. Norley, S., Beer, B., Binninger-Schinzel, D., Cosma, C. & Kurth, R. (1996). Protection from pathogenic SIVmac challenge following short-term infection with a Nef-deficient attenuated virus. Virology 219, 195-205.
32. Petry, H., Dittmer, U., Stahl-Hennig, C., Coulibaly, C., Makoschey, B., Fuchs, D., Wachter, H., Tolle, T., Morys-Wortman, C., Kaup, F.-J., Jurkiewicz, E., Lüke, W. & Hunsmann, G. (1995). Reactivation of human immunodeficiency virus type 2 in macaques after simian immunodeficiency virus SIVmac superinfection. Journal of Virology 69, 5117-5123.
33. Rud, E. W., Jon, J. R., Larder, B. A., Clarke, B. E., Cook, N. & Cranage, M. P. (1992). Infectious molecular clone of SIVmac32H: nef deletion controls ability to reisolate virus from rhesus macaques. In Vaccines 92, pp. 229-235. Edited by F. Brown, R. M. Chanock, H. S. Ginsberg & R. A. Lemer. New York: Cold Spring Harbor Laboratory Press.
34. Rud, E. W., Cranage, M., Yon, J., Quirk, J., Ogilvie, L., Cook, N., Webster, S., Dennis, M. & Clarke, B. E. (1994a). Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing size variants. Journal of General Virology 75, 529-543.
35. Rud, E. W., Ogilvie, L., Clarke, B. E., Almond, N., Kent, K., Chan, L., Page, M., Kitchin, P., Stott, J., Cook, N., Sharpe, S., Ash worth, T., Dennis, M., Hall, G. & Cranage, M. P. (1994b). A naturally attenuated SIVmac32H vaccine or viral interference. In Vaccines 94, pp. 217-223. Edited by E. Norrby, F. Brown, R. M. Chanock & H. S. Ginsberg. New York: Cold Spring Harbor Laboratory Press.
36. Shafferman, A., Jahrling, P. B., Benveniste, R. E., Lewis, M. G., Phipps, T. J., Eden-McCutchan, F., Sadoff, J., Eddy, G. A. & Burke, D. S. (1991). Protection of macaques with a simian immunodeficiency virus envelope peptide vaccine based on conserved human immunodeficiency virus type 1 sequences. Proceedings of the National Academy of Sciences, USA 88, 7126-7130.
37. Stahl-Hennig, C., Voss, G., Nick, S., Petry, H., Fuchs, D., Wachter, H., Coulibaly, C., Lüke, W. & Hunsmann, G. (1992). Immunization with Tween-ether-treated SIV adsorbed onto aluminium hydroxide protects monkeys against experimental SIV infection. Virology 186, 588-596.
38. Stahl-Hennig, C., Coulibaly, C., Petry, H., Voss, G., Dittmer, U., Bodemer, W., Makoschey, B., Jurkiewicz, E., Luke, W. & Hunsmann, G. (1994). Immunization with virion-derived glycoprotein 130 from HIV-2 or SIV protects macaques against challenge virus grown in human or simian cells or prepared ex vivo. AIDS Research and Human Retroviruses 10, S27-S32.
39. Sutjipto, S., Pedersen, N. C., Miller, C. J., Gardner, M. B., Hanson, C. V., Gettie, A., Jennings, M., Higgins, J. & Marx, P. A. (1990). Inactivated simian immunodeficiency virus vaccine failed to protect rhesus macaques from intravenous or genital mucosal infection but delayed disease in intravenously exposed animals. Journal of Virology 64, 2290-2297.
40. Whatmore, A. M., Cook, N., Hall, G. H., Sharpe, S., Rud, E. W. & Cranage, M. P. (1995). Repair and evolution of nef in vivo modulates simian immunodeficiency virus virulence. Journal of Virology 69, 5117-5123.
41. Wyand, M. S., Manson, K. H., Garcia-Moll, M., Montefiori, D. & Desrosiers, R. C. (1996). Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. Journal of Virology 70, 3724-3733.